Discover
RFL
Rafael Holdings, Inc.
3.78
2800 x undefined
400 x undefined
bid
ask
+
0.50
15.24%
1600 @ 04:00 PM
3.67 -0.11 (2.91%)
| Ytd | 220.34% | |
| 1y | 101.06% |
3.34
day range
3.96
1.12
52 week range
3.96
| Open | 3.36 | Prev Close | 3.28 | Low | 3.34 | High | 3.96 | Mkt Cap | 196.56M |
| Vol | 622.63K | Avg Vol | 161.55K | EPS | -0.72 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.07 | Short Ratio | 1.80 | Inst. Own | 10.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 06-11 | 50-d Avg | 1.74 | 200-d Avg | 1.40 | 1yr Est | 0.00 |
RFL News
seekingalpha.com
Rafael Holdings: The Second Half Of Calendar 2026 Could Define This Company Forever
Rafael Holdings' Phase 3 clinical trial of a drug named Trappsol Cyclo just got over. Results of the
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
Rafael Holdings Q3 EPS $(0.08) Up From $(0.19) YoY, Sales $179.000K Down From $362.000K YoY
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.08) per share. This is a 57.89 percent i
benzinga.com
Rafael Holdings Announces Last Patient Completed Final 96-Week Study Visit In Pivotal Phase 3 Transp
The company has had a pre-NDA meeting with the FDA and expects to submit an NDA in second half of ca
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session